CN113631155A - 消毒剂组合物、其制备方法和用途 - Google Patents
消毒剂组合物、其制备方法和用途 Download PDFInfo
- Publication number
- CN113631155A CN113631155A CN202080021892.7A CN202080021892A CN113631155A CN 113631155 A CN113631155 A CN 113631155A CN 202080021892 A CN202080021892 A CN 202080021892A CN 113631155 A CN113631155 A CN 113631155A
- Authority
- CN
- China
- Prior art keywords
- disinfectant composition
- composition according
- zinc
- acid
- disinfectant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 120
- 239000000645 desinfectant Substances 0.000 title claims abstract description 119
- 238000002360 preparation method Methods 0.000 title description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 92
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 claims abstract description 48
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims abstract description 47
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims abstract description 39
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 claims abstract description 39
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 claims abstract description 39
- 229940116229 borneol Drugs 0.000 claims abstract description 36
- 238000004659 sterilization and disinfection Methods 0.000 claims abstract description 36
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 claims abstract description 34
- 150000003751 zinc Chemical class 0.000 claims abstract description 29
- 239000004202 carbamide Substances 0.000 claims abstract description 24
- 150000007524 organic acids Chemical class 0.000 claims abstract description 22
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 50
- 239000000243 solution Substances 0.000 claims description 44
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 42
- 238000003756 stirring Methods 0.000 claims description 41
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 30
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 28
- 241000700605 Viruses Species 0.000 claims description 27
- 230000003020 moisturizing effect Effects 0.000 claims description 26
- 150000004676 glycans Chemical class 0.000 claims description 23
- 229920001282 polysaccharide Polymers 0.000 claims description 23
- 239000005017 polysaccharide Substances 0.000 claims description 23
- 239000003205 fragrance Substances 0.000 claims description 22
- 239000002562 thickening agent Substances 0.000 claims description 20
- 239000003974 emollient agent Substances 0.000 claims description 19
- 239000007788 liquid Substances 0.000 claims description 18
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 claims description 17
- CXVGEDCSTKKODG-UHFFFAOYSA-N sulisobenzone Chemical compound C1=C(S(O)(=O)=O)C(OC)=CC(O)=C1C(=O)C1=CC=CC=C1 CXVGEDCSTKKODG-UHFFFAOYSA-N 0.000 claims description 17
- 229960000368 sulisobenzone Drugs 0.000 claims description 16
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 claims description 15
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 claims description 15
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 claims description 15
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 15
- 239000005642 Oleic acid Substances 0.000 claims description 15
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 claims description 15
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 claims description 15
- 238000000034 method Methods 0.000 claims description 15
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 claims description 15
- 229930003427 Vitamin E Natural products 0.000 claims description 14
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 14
- 239000004310 lactic acid Substances 0.000 claims description 14
- 235000014655 lactic acid Nutrition 0.000 claims description 14
- 239000011709 vitamin E Substances 0.000 claims description 14
- 229940046009 vitamin E Drugs 0.000 claims description 14
- 235000019165 vitamin E Nutrition 0.000 claims description 14
- 241000894006 Bacteria Species 0.000 claims description 13
- 238000002156 mixing Methods 0.000 claims description 13
- WEEGYLXZBRQIMU-UHFFFAOYSA-N 1,8-cineole Natural products C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 claims description 12
- 229960005233 cineole Drugs 0.000 claims description 12
- OWVLYQRCCIEOPF-QHTZZOMLSA-L zinc;(2s)-5-oxopyrrolidine-2-carboxylate Chemical compound [Zn+2].[O-]C(=O)[C@@H]1CCC(=O)N1.[O-]C(=O)[C@@H]1CCC(=O)N1 OWVLYQRCCIEOPF-QHTZZOMLSA-L 0.000 claims description 11
- WEEGYLXZBRQIMU-WAAGHKOSSA-N Eucalyptol Chemical compound C1C[C@H]2CC[C@]1(C)OC2(C)C WEEGYLXZBRQIMU-WAAGHKOSSA-N 0.000 claims description 10
- 239000002202 Polyethylene glycol Substances 0.000 claims description 10
- 229920001223 polyethylene glycol Polymers 0.000 claims description 10
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 claims description 10
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 claims description 10
- 229920001661 Chitosan Polymers 0.000 claims description 8
- 229940045110 chitosan Drugs 0.000 claims description 8
- 229940113115 polyethylene glycol 200 Drugs 0.000 claims description 6
- DTGKSKDOIYIVQL-MRTMQBJTSA-N Isoborneol Natural products C1C[C@@]2(C)[C@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-MRTMQBJTSA-N 0.000 claims description 5
- DOOTYTYQINUNNV-UHFFFAOYSA-N Triethyl citrate Chemical compound CCOC(=O)CC(O)(C(=O)OCC)CC(=O)OCC DOOTYTYQINUNNV-UHFFFAOYSA-N 0.000 claims description 5
- WHMDKBIGKVEYHS-IYEMJOQQSA-L Zinc gluconate Chemical compound [Zn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O WHMDKBIGKVEYHS-IYEMJOQQSA-L 0.000 claims description 5
- CANRESZKMUPMAE-UHFFFAOYSA-L Zinc lactate Chemical compound [Zn+2].CC(O)C([O-])=O.CC(O)C([O-])=O CANRESZKMUPMAE-UHFFFAOYSA-L 0.000 claims description 5
- ZOIORXHNWRGPMV-UHFFFAOYSA-N acetic acid;zinc Chemical compound [Zn].CC(O)=O.CC(O)=O ZOIORXHNWRGPMV-UHFFFAOYSA-N 0.000 claims description 5
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 claims description 5
- 229960004889 salicylic acid Drugs 0.000 claims description 5
- 239000001069 triethyl citrate Substances 0.000 claims description 5
- VMYFZRTXGLUXMZ-UHFFFAOYSA-N triethyl citrate Natural products CCOC(=O)C(O)(C(=O)OCC)C(=O)OCC VMYFZRTXGLUXMZ-UHFFFAOYSA-N 0.000 claims description 5
- 235000013769 triethyl citrate Nutrition 0.000 claims description 5
- WGIWBXUNRXCYRA-UHFFFAOYSA-H trizinc;2-hydroxypropane-1,2,3-tricarboxylate Chemical compound [Zn+2].[Zn+2].[Zn+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O WGIWBXUNRXCYRA-UHFFFAOYSA-H 0.000 claims description 5
- 239000004246 zinc acetate Substances 0.000 claims description 5
- 229960000314 zinc acetate Drugs 0.000 claims description 5
- 235000013904 zinc acetate Nutrition 0.000 claims description 5
- 239000011592 zinc chloride Substances 0.000 claims description 5
- 235000005074 zinc chloride Nutrition 0.000 claims description 5
- 229960001939 zinc chloride Drugs 0.000 claims description 5
- 239000011746 zinc citrate Substances 0.000 claims description 5
- 235000006076 zinc citrate Nutrition 0.000 claims description 5
- 229940068475 zinc citrate Drugs 0.000 claims description 5
- 239000011670 zinc gluconate Substances 0.000 claims description 5
- 235000011478 zinc gluconate Nutrition 0.000 claims description 5
- 229960000306 zinc gluconate Drugs 0.000 claims description 5
- 239000011576 zinc lactate Substances 0.000 claims description 5
- 235000000193 zinc lactate Nutrition 0.000 claims description 5
- 229940050168 zinc lactate Drugs 0.000 claims description 5
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 claims description 5
- 229960001763 zinc sulfate Drugs 0.000 claims description 5
- 229910000368 zinc sulfate Inorganic materials 0.000 claims description 5
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims description 4
- 229920000936 Agarose Polymers 0.000 claims description 4
- 229920002307 Dextran Polymers 0.000 claims description 4
- 241000233866 Fungi Species 0.000 claims description 4
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 claims description 4
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 claims description 4
- 239000001913 cellulose Substances 0.000 claims description 4
- 229920002678 cellulose Polymers 0.000 claims description 4
- 229920000669 heparin Polymers 0.000 claims description 4
- 229960002897 heparin Drugs 0.000 claims description 4
- 229920002674 hyaluronan Polymers 0.000 claims description 4
- 229960003160 hyaluronic acid Drugs 0.000 claims description 4
- 239000012266 salt solution Substances 0.000 claims description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 32
- 241000222122 Candida albicans Species 0.000 abstract description 4
- 241000991587 Enterovirus C Species 0.000 abstract description 4
- 241000588724 Escherichia coli Species 0.000 abstract description 4
- 241001263478 Norovirus Species 0.000 abstract description 4
- 241000589517 Pseudomonas aeruginosa Species 0.000 abstract description 4
- 241000191967 Staphylococcus aureus Species 0.000 abstract description 4
- 229940095731 candida albicans Drugs 0.000 abstract description 4
- 241000701161 unidentified adenovirus Species 0.000 abstract description 4
- 241001505332 Polyomavirus sp. Species 0.000 abstract description 3
- 230000000638 stimulation Effects 0.000 abstract description 2
- 238000012360 testing method Methods 0.000 description 16
- 235000011187 glycerol Nutrition 0.000 description 14
- 239000008367 deionised water Substances 0.000 description 13
- 229910021641 deionized water Inorganic materials 0.000 description 13
- 229960002969 oleic acid Drugs 0.000 description 12
- 230000001954 sterilising effect Effects 0.000 description 9
- 241001465754 Metazoa Species 0.000 description 8
- 230000000052 comparative effect Effects 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- 230000000249 desinfective effect Effects 0.000 description 6
- 201000010099 disease Diseases 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 230000002779 inactivation Effects 0.000 description 6
- 230000003612 virological effect Effects 0.000 description 6
- 125000003118 aryl group Chemical group 0.000 description 5
- 230000007794 irritation Effects 0.000 description 5
- 244000309711 non-enveloped viruses Species 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 239000000725 suspension Substances 0.000 description 5
- 241000283973 Oryctolagus cuniculus Species 0.000 description 4
- 206010040880 Skin irritation Diseases 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- 229960005150 glycerol Drugs 0.000 description 4
- 238000010438 heat treatment Methods 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- 229940074928 isopropyl myristate Drugs 0.000 description 4
- 230000036556 skin irritation Effects 0.000 description 4
- 231100000475 skin irritation Toxicity 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 230000002195 synergetic effect Effects 0.000 description 4
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- 150000001298 alcohols Chemical class 0.000 description 3
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 230000000415 inactivating effect Effects 0.000 description 3
- 235000021313 oleic acid Nutrition 0.000 description 3
- 239000000516 sunscreening agent Substances 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 229940045136 urea Drugs 0.000 description 3
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 2
- 241000723346 Cinnamomum camphora Species 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 206010040914 Skin reaction Diseases 0.000 description 2
- 208000036142 Viral infection Diseases 0.000 description 2
- 230000002745 absorbent Effects 0.000 description 2
- 239000002250 absorbent Substances 0.000 description 2
- 230000000845 anti-microbial effect Effects 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 229930008380 camphor Natural products 0.000 description 2
- 229960000846 camphor Drugs 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 230000002354 daily effect Effects 0.000 description 2
- 230000002951 depilatory effect Effects 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 230000001965 increasing effect Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 210000004400 mucous membrane Anatomy 0.000 description 2
- 231100000344 non-irritating Toxicity 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 235000005985 organic acids Nutrition 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 2
- 238000011012 sanitization Methods 0.000 description 2
- 230000035483 skin reaction Effects 0.000 description 2
- 231100000430 skin reaction Toxicity 0.000 description 2
- 230000000475 sunscreen effect Effects 0.000 description 2
- 229960005486 vaccine Drugs 0.000 description 2
- 230000009385 viral infection Effects 0.000 description 2
- 230000003253 viricidal effect Effects 0.000 description 2
- DTGKSKDOIYIVQL-QXFUBDJGSA-N (-)-borneol Chemical compound C1C[C@]2(C)[C@H](O)C[C@H]1C2(C)C DTGKSKDOIYIVQL-QXFUBDJGSA-N 0.000 description 1
- 229930006703 (-)-borneol Natural products 0.000 description 1
- 125000002006 1,8-cineol group Chemical group 0.000 description 1
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 208000031504 Asymptomatic Infections Diseases 0.000 description 1
- PXRCIOIWVGAZEP-UHFFFAOYSA-N Camphene hydrate Chemical compound C1CC2C(O)(C)C(C)(C)C1C2 PXRCIOIWVGAZEP-UHFFFAOYSA-N 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 102000004895 Lipoproteins Human genes 0.000 description 1
- 108090001030 Lipoproteins Proteins 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 102000007562 Serum Albumin Human genes 0.000 description 1
- 108010071390 Serum Albumin Proteins 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 231100000460 acute oral toxicity Toxicity 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000001088 anti-asthma Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 239000000924 antiasthmatic agent Substances 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 238000011888 autopsy Methods 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000003851 biochemical process Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical group 0.000 description 1
- 230000000973 chemotherapeutic effect Effects 0.000 description 1
- RFFOTVCVTJUTAD-UHFFFAOYSA-N cineole Natural products C1CC2(C)CCC1(C(C)C)O2 RFFOTVCVTJUTAD-UHFFFAOYSA-N 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 239000006184 cosolvent Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 230000000120 cytopathologic effect Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 239000000551 dentifrice Substances 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 238000012631 diagnostic technique Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 239000000686 essence Substances 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000004519 grease Substances 0.000 description 1
- 229940125721 immunosuppressive agent Drugs 0.000 description 1
- 239000003018 immunosuppressive agent Substances 0.000 description 1
- 239000012678 infectious agent Substances 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000035987 intoxication Effects 0.000 description 1
- 231100000566 intoxication Toxicity 0.000 description 1
- 239000002085 irritant Substances 0.000 description 1
- 231100000021 irritant Toxicity 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 229940127554 medical product Drugs 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 229930003658 monoterpene Natural products 0.000 description 1
- -1 monoterpene compound Chemical class 0.000 description 1
- 235000002577 monoterpenes Nutrition 0.000 description 1
- 210000000214 mouth Anatomy 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 231100000956 nontoxicity Toxicity 0.000 description 1
- 230000009965 odorless effect Effects 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000021315 omega 9 monounsaturated fatty acids Nutrition 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 229960005323 phenoxyethanol Drugs 0.000 description 1
- 239000011505 plaster Substances 0.000 description 1
- 239000002985 plastic film Substances 0.000 description 1
- 229920006255 plastic film Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 238000010008 shearing Methods 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 229910021653 sulphate ion Inorganic materials 0.000 description 1
- 230000009182 swimming Effects 0.000 description 1
- 231100000378 teratogenic Toxicity 0.000 description 1
- 230000003390 teratogenic effect Effects 0.000 description 1
- 229940126585 therapeutic drug Drugs 0.000 description 1
- 229940034610 toothpaste Drugs 0.000 description 1
- 239000000606 toothpaste Substances 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 238000002723 toxicity assay Methods 0.000 description 1
- 239000012137 tryptone Substances 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
- A01N25/02—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests containing liquids as carriers, diluents or solvents
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N31/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic oxygen or sulfur compounds
- A01N31/02—Acyclic compounds
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N31/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic oxygen or sulfur compounds
- A01N31/06—Oxygen or sulfur directly attached to a cycloaliphatic ring system
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N37/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
- A01N37/02—Saturated carboxylic acids or thio analogues thereof; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N37/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
- A01N37/36—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing at least one carboxylic group or a thio analogue, or a derivative thereof, and a singly bound oxygen or sulfur atom attached to the same carbon skeleton, this oxygen or sulfur atom not being a member of a carboxylic group or of a thio analogue, or of a derivative thereof, e.g. hydroxy-carboxylic acids
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/34—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom
- A01N43/36—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom five-membered rings
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N59/00—Biocides, pest repellants or attractants, or plant growth regulators containing elements or inorganic compounds
- A01N59/16—Heavy metals; Compounds thereof
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N65/00—Biocides, pest repellants or attractants, or plant growth regulators containing material from algae, lichens, bryophyta, multi-cellular fungi or plants, or extracts thereof
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N65/00—Biocides, pest repellants or attractants, or plant growth regulators containing material from algae, lichens, bryophyta, multi-cellular fungi or plants, or extracts thereof
- A01N65/08—Magnoliopsida [dicotyledons]
- A01N65/12—Asteraceae or Compositae [Aster or Sunflower family], e.g. daisy, pyrethrum, artichoke, lettuce, sunflower, wormwood or tarragon
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N65/00—Biocides, pest repellants or attractants, or plant growth regulators containing material from algae, lichens, bryophyta, multi-cellular fungi or plants, or extracts thereof
- A01N65/08—Magnoliopsida [dicotyledons]
- A01N65/24—Lauraceae [Laurel family], e.g. laurel, avocado, sassafras, cinnamon or camphor
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01P—BIOCIDAL, PEST REPELLANT, PEST ATTRACTANT OR PLANT GROWTH REGULATORY ACTIVITY OF CHEMICAL COMPOUNDS OR PREPARATIONS
- A01P1/00—Disinfectants; Antimicrobial compounds or mixtures thereof
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01P—BIOCIDAL, PEST REPELLANT, PEST ATTRACTANT OR PLANT GROWTH REGULATORY ACTIVITY OF CHEMICAL COMPOUNDS OR PREPARATIONS
- A01P3/00—Fungicides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Environmental Sciences (AREA)
- Plant Pathology (AREA)
- Agronomy & Crop Science (AREA)
- Dentistry (AREA)
- Pest Control & Pesticides (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Organic Chemistry (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Biotechnology (AREA)
- Toxicology (AREA)
- Virology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Inorganic Chemistry (AREA)
- Botany (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
本发明涉及消毒剂领域。本发明提供了一种消毒剂组合物,其按质量百分比计包含:乙醇59%‑88%;异丙醇1.5%‑8%;尿素0.2%‑8%;有机酸0.2%‑6%;龙脑0.1%‑2%;锌盐0.1%‑3%;余量为水。本发明的消毒剂组合物可应用于各种无生命物体表面消毒,还可以应用于皮肤消毒,有效地对金黄色葡萄球菌、大肠杆菌、白色念球珠菌、铜绿假单胞菌、脊髓灰质炎病毒、腺病毒、诺如病毒、多瘤病毒等起到杀灭作用,达到严格的消毒要求,而且对皮肤无刺激。
Description
技术领域
本发明涉及消毒剂领域,尤其涉及一种用于有生命和无生命的表面的基于醇的杀病毒消毒剂及其制备方法。
背景技术
近年来,消毒剂变得越来越重要:在医疗领域,例如在医院或医疗实践中,以及在食品和制药工业中或在公共交通繁忙的地方,例如在游泳池或公共厕所中,越来越多地定期使用消毒剂,如此可以保护人类和动物免受诸如细菌、真菌或病毒等病原体的侵害,并且可以极大地限制病原体的传播。同时,对于即将到来的流行病,这尤其重要。
现在,针对细菌、真菌和包膜病毒(带有脂蛋白包膜的病毒)存在各种各样的市售基于酒精的消毒剂。尽管大多数此类消毒剂具有广泛且相对较快的抗菌活性,但它们灭活非包膜病毒的能力通常受到限制(Kampf G,Kramer A.Epidemiologic background ofhand hygiene and evaluation of the most important agents for scrubs andrubs.Clin Microbiol Rev 2004;17:863—893),但是,对病毒有效的灭活非常重要。
病毒性疾病在人类疾病中,占有十分重要的位置,在传染病中的比例还有上升的趋势,近年,还常常出现新的病毒性疾病暴发。同时,由于病毒感染没有特效治疗药物,疫苗的研究、生产又严重滞后,给疾病的预防与控制提出了严峻的挑战。而且,下列因素还会加重病毒病危害。如:免疫抑制剂的使用、器官与组织移植、旅游、国际贸易、生活方式的改变、易感群体的增加(幼儿园、敬老院)、疫苗的缺乏、化学治疗方法的不足、慢性病、新出现的病毒、变异与重组的病毒、亚临床感染、病毒感染的诊断技术的落后、气候的异常变化、新医疗产品的使用、水质与空气质量恶化等。
消毒是防控病毒性疾病的重要手段之一。基于现有的消毒剂不足,本发明人发明一种用于有生命或无生命物体表面的消毒剂,特别是针对病毒的消毒剂。
发明内容
本发明的目的在于提供病毒消毒剂及其制备方法,可应用于各种无生命物体表面消毒,还可以应用于皮肤消毒,有效地对金黄色葡萄球菌、大肠杆菌、白色念球珠菌、铜绿假单胞菌、脊髓灰质炎病毒、腺病毒、诺如病毒、多瘤病毒等起到杀灭作用,达到严格的消毒要求,而且对皮肤无刺激。
本发明提供了消毒剂组合物,其按质量百分比计包含:
余量为水,优选去离子水。
在一个实施方案中,乙醇含量可以是65%-80%。
在一个实施方案中,异丙醇含量可以是5%-7%。
在一个实施方案中,尿素含量可以是1%-2%。
在一个实施方案中,龙脑含量可以是0.2%-1%。
在一个实施方案中,锌盐含量可以是0.1%-0.5%。
在一个实施方案中,消毒剂组合物还包含保湿润肤剂。优选地,消毒剂组合物包含0.05%-30%保湿润肤剂。
在一个实施方案中,消毒剂组合物还包含芳香剂。优选地,消毒剂组合物包含0.05%-1%芳香剂。
在一个实施方案中,消毒剂组合物还包含增稠剂。优选地,消毒剂组合物包含0.05%-10%增稠剂。
在一个实施方案中,有机酸选自柠檬酸、水杨酸、乙酸和乳酸。
在一个实施方案中,消毒剂组合物包含0.5%-2%柠檬酸。在一个实施方案中,消毒剂组合物包含1-5%乳酸。
在一个实施方案中,龙脑选自左旋龙脑、右旋龙脑和异龙脑。优选地,龙脑为左旋龙脑。
在一个实施方案中,锌盐选自葡萄糖酸锌、吡咯烷酮羧酸锌、柠檬酸锌、醋酸锌、乳酸锌、氯化锌和硫酸锌。优选地,锌盐是吡咯烷酮羧酸锌。
在一个实施方案中,保湿润肤剂选自丙三醇、油酸、维生素E和肉豆蔻酸异丙酯。
在一个实施方案中,保湿润肤剂是油酸或丙三醇、维生素E和肉豆蔻酸异丙酯。
在一个实施方案中,油酸含量为0.1-1%。在一个实施方案中,丙三醇含量为1%-25%。在一个实施方案中,维生素E含量为0.1%-1%。在一个实施方案中,肉豆蔻酸异丙酯的含量为0.1%-2%。
在一个实施方案中,芳香剂包含药草型香精。优选地,药草型香精是桉叶油醇。优选地,桉叶油醇的含量为0.1%-0.5%。
在一个实施方案中,增稠剂选自聚乙二醇、柠檬酸三乙酯和多糖。
在一个实施方案中,聚乙二醇的含量为1-5%。在一个实施方案中,多糖含量为0.05%-10%。
在一个实施方案中,聚乙二醇是聚乙二醇200。
在一个实施方案中,多糖选自琼脂糖、葡聚糖、纤维素硫酸酯、壳聚糖、肝素和透明质酸。
在一个实施方案中,多糖是壳聚糖。
在一个实施方案中,消毒剂组合物还包含二苯甲酮-4。优选地,消毒剂组合物包含0.1%-1.5%,优选0.5%二苯甲酮-4。
在另一个方面,本发明提供了制备本发明的消毒剂组合物的方法,其包括:
(a)将乙醇和异丙醇混合并搅拌均匀;和
(b)将尿素、有机酸、龙脑和锌盐溶液加入到(a)溶液中,搅拌至完全溶解,得到均相澄明的液体。
在一个实施方案中,(b)步骤还包括将保湿润肤剂、芳香剂、增稠剂和/或二苯甲酮-4加入到(a)溶液中。
在又一个方面,本发明提供了本发明的消毒剂组合物用于皮肤消毒,特别是用于卫生手和外科手的消毒,或者用于杀灭有生命和无生命的表面的细菌、真菌和病毒的用途。
在一个实施方案中,消毒剂组合物按质量百分比计包含:
其余为水,优选去离子水。
在另一个实施方案中,消毒剂组合物按质量百分比计包含:
其余为水,优选去离子水。
在一个实施方案中,消毒剂组合物用于物体表面消毒。
在另一个方面,本发明提供了制备消毒剂组合物的方法,其包括:
(a)将乙醇和异丙醇混合并搅拌均匀;
(b)然后依次将尿素、有机酸、龙脑加入到(a)溶液中,搅拌至完全溶解;
(c)向(b)溶液中分别加入增稠剂、保湿润肤剂和芳香剂,边加边搅拌,使溶液混合均匀;
(d)将锌盐加入到水,优选去离子水中,搅拌至完全溶解;
(e)向(d)溶液中缓慢加入(c)溶液,快速搅拌,使溶液混合均匀,得到均相澄明的液体。
在一个实施方案中,各步骤都是在常压下进行的,同时搅拌过程中控制温度在20±2℃。
在一个实施方案中,保湿润肤剂是油酸;所述增稠剂选自聚乙二醇和柠檬酸三乙酯。
在一个实施方案中,提供了制备消毒剂组合物的方法,其包括:
(a)将乙醇和异丙醇混合并搅拌均匀;
(b)依次将尿素、龙脑、二苯甲酮-4加入到(a)溶液中,搅拌至完全溶解;
(c)向(b)溶液中分别加入丙三醇、肉豆蔻酸异丙酯、维生素E和芳香剂,边加边搅拌,使溶液混合均匀;
(d)将锌盐、多糖、有机酸加入到水,优选去离子水中,加热并搅拌至完全溶解;
(e)向(d)溶液中缓慢加入(c)溶液,快速搅拌,使溶液混合均匀,得到均相澄明的液体;
在一个实施方案中,方法的各步骤都是在常压下进行的,同时搅拌过程中控制温度在20-40℃。
在又一个方面,提供了消毒剂组合物用于皮肤的消毒,特别是用于卫生手和外科手的消毒的用途。
根据本发明的消毒剂组合物或根据本发明的方法制备的消毒剂组合物用于皮肤消毒,特别是卫生手和外科手的消毒,可有效地对金黄色葡萄球菌、大肠杆菌、白色念球珠菌、铜绿假单胞菌、脊髓灰质炎病毒、腺病毒、诺如病毒、多瘤病毒等起到杀灭作用,达到严格的消毒要求,而且对皮肤无刺激。根据本发明的消毒剂组合物可以制备成试剂盒。
本发明至少具备以下有益的效果:
1.本发明的消毒剂组合物对细菌,例如金黄色葡萄球菌、大肠杆菌、白色念球珠菌、铜绿假单胞菌具有杀菌效应。如实施例中证明,本发明的消毒剂组合物具有有效的杀菌对数值,即大于5.0的值。
2.本发明的消毒剂组合物对病毒,尤其是无包膜的病毒,例如脊髓灰质炎病毒、腺病毒、诺如病毒和多瘤病毒具有杀病毒效应。如实施例中证明,本发明的消毒剂组合物对无包膜病毒具有有效的病毒灭活对数值,即灭活对数值≥4.00。
3.在本申请的组合物中添加润肤、保湿和/或防晒成分未影响组合物的消毒性能。通过添加这些成分可以避免单次或多次使用过程中对皮肤,尤其是手的刺激,如实施例中证明的。
4.本发明发现以任意顺序添加本发明的组合物的成分时容易产生沉淀,形成悬浮溶液。相反,当先添加乙醇和异丙醇,后添加其它成分时,可以得到无色澄清透明液体,有效发挥各组分的功能。
5.本发明的组合物的各组分,例如乙醇、异丙醇、尿素、有机酸、龙脑和锌盐能够彼此起到协同效果。例如,组合物的一种组分能够促进其它成分的杀菌或灭活病毒的效果。以龙脑来说,现有技术表明该成分不具备短时间灭菌的能力,不适用于手消毒剂。但是,本发明表明其与组合物中的其它组分能够协同在短时间(1分钟)内灭活病毒,使组合物适用作手消毒剂。
具体实施方式
醇类消毒剂具有悠久的历史,在医疗机构的消毒中占有重要地位,属于中效消毒剂,主要用于皮肤消毒。常用的品种主要有乙醇、丙醇和异丙醇,还不断有苯氧乙醇和某些植物醇类等更大分子的醇类加入消毒产品行列。由于醇类与其他杀菌因子具有良好的协同作用,近年来复方醇类消毒剂得到迅速发展,应用于皮肤和手消毒等方面。
皮肤消毒一般要求在较短的时间(例如1分钟)内杀灭细菌和/或病毒。尽管现有技术中存在大量对细菌和/或病毒具有杀灭性质的物质,但是这些物质无法满足在短时间内杀灭细菌和/或病毒的效果。发明人发现了通过组合本发明的组合物的各组分能够产生协同效果,在短时间内杀灭细菌和/或病毒。
本发明的醇类消毒剂组合物可以包含乙醇、异丙醇、尿素、有机酸和龙脑、锌盐。
在本文中,如无相反说明,在提及组分时“%”为质量百分比。
本发明中,乙醇分子式为CH3CH2OH,相对分子质量46.07。为无色透明液体,易挥发;是最常见、也是最普通最为人所熟悉的消毒剂。尽管酒精基手擦方式通常具有更广泛且相对较快的抗菌活性,但它们灭活非包膜病毒的能力通常受到限制(Kampf G,KramerA.Epidemiologic background of hand hygiene and evaluation of the mostimportant agents for scrubs and rubs.Clin Microbiol Rev 2004;17:863—893),提高乙醇含量可能在某种程度上解决了这一问题,但增加了组织毒性的风险并降低杀灭细菌的能力。在本文中,乙醇在消毒剂组合物中的含量可以为59%-88%。在一个实施方案中,乙醇在消毒剂组合物中的含量可以为65%-80%。例如,乙醇的含量可以是70%或75%。
本发明中,异丙醇分子式为CH3CH2CH2OH,相对分子量为60.10,为无色透明液体,易挥发,有较浓的醇的气味,其杀菌效果与乙醇处于同一水平。在本文中,异丙醇在消毒剂组合物中的含量可以为1.5%-8%。在一个实施方案中,异丙醇在消毒剂组合物中的含量可以为5%-7%。例如,异丙醇的含量是5.5%或6%。
本发明中,有机酸可以包括柠檬酸、水杨酸、乙酸和乳酸等中的一种或多种。优选地,有机酸是柠檬酸或者乳酸。本发明中,加入有机酸可以提高消毒剂的消毒能力。乳酸,又名2-羟基丙酸,是一种化合物,它在多种生物化学过程中起作用。它是一种羧酸,分子式为C3H6O3,在医药方面广泛用作防腐剂、载体剂、助溶剂、药物制剂、pH调节剂等。在一个实施方案中,柠檬酸含量为0.5%-2%,或者乳酸含量为1-5%。例如,柠檬酸含量为1%,或者乳酸含量为3%。
本发明中,龙脑可以包括左旋龙脑、右旋龙脑和异龙脑中的一种或多种。优选地,龙脑是左旋龙脑。左旋龙脑(L-borneol),又名艾片、艾脑、左旋冰片等,外型似冰,是龙脑(borneol)的两个旋光体之一;分子量154.24,分子式C10H17OH;极微溶于水,易溶于有机溶剂;具有类似樟脑和松木的香气[9]。有文献数据表明龙脑杀菌和病毒的时间较长,不能到达手消毒剂的要求。在本发明中,龙脑的主要作用是增强乙醇渗透细菌和病毒的内部,提高乙醇杀灭细菌和病毒的效力,降低乙醇对黏膜的刺激性。在一个实施方案中,龙脑的含量为0.1%-2%。在一个实施方案中,龙脑的含量为0.2%-1%。
本发明中,锌盐可以有杀菌抑菌的功能。本发明中,锌盐可以包含葡萄糖酸锌、吡咯烷酮羧酸锌、柠檬酸锌、醋酸锌、乳酸锌、氯化锌和硫酸锌等中的一种或多种,优选是吡咯烷酮羧酸锌。吡咯烷酮羧酸锌,分子式C10H12N2O6Zn,为白色或类白色固体。在一个实施方案中,锌盐的含量为0.1%-3%。在一个实施方案中,锌盐的含量为0.1%-0.5%。例如,锌盐的含量为0.2%。
本发明中,尿素指分子式为CH4N2O的碳酸二酰胺。尿素是一种很好用的保湿品,它就存在于肌肤的角质层当中,属于肌肤天然保湿因子的主要成分,对肌肤来说,尿素具有保湿作用还具有柔软角质的功效,所以也能够防止角质层阻塞毛细孔。在一个实施方案中,尿素的含量为0.2%-8%。在一个实施方案中,尿素的含量为1%-2%。
本发明的消毒剂组合物还可以包含芳香剂、保湿润肤剂和增稠剂中的一种或多种。优选地,本发明的消毒剂组合物还可以包含芳香剂、保湿润肤剂和增稠剂。
本发明中,芳香剂包含药草型香精,特别是桉叶油醇。桉叶油醇,分子式为C10H18O,又名(1,8-)桉树脑,桉叶素桉树精,属单萜类化合物。无色液体,味辛冷,有与樟脑相似的气味。用于药草型香精,配制精油及牙膏、牙粉、口腔清凉剂、药皂等香精,也较多用于医药。具有解热、消炎、抗菌、防腐、平喘及镇痛作用。在本发明中主要用于调整消毒剂气味。在一个实施方案中,芳香剂的含量为0.05%-1%。在一个实施方案中,芳香剂的含量为0.1%-0.5%。
本发明中,保湿润肤剂可以包括丙三醇、油酸、维生素E、肉豆蔻酸异丙酯中的一种或多种。在一个实施方案中,保湿润肤剂可以是油酸。在另一个实施方案中,保湿润肤剂可以是丙三醇、维生素E和肉豆蔻酸异丙酯。保湿润肤剂的含量可以是0.05%-30%。例如,油酸含量为0.1-1%。
本发明中,丙三醇,分子式为C3H8O3,又名1,2,3-丙三醇、甘油;无色、无臭、味甜,具有滋润皮肤的作用。油酸,分子式为C18H34O2,是一种单不饱和Omega-9脂肪酸,存在于动植物体内,为无色油状液体。肉豆蔻酸异丙酯,分子式为C17H34O2,分子量为270.4507,又名豆蔻酸异丙酯;十四酸异丙酯,为无色透明油状液体,不溶于水;能与醇、醚、亚甲基氯、油脂等有机溶剂混溶;具有保湿和滋润皮肤的作用。在本发明中,丙三醇、油酸、维生素E、肉豆蔻酸异丙酯都是保湿和滋润皮肤的作用。丙三醇含量可以为1%-25%。维生素E含量可以为0.1%-1%。肉豆蔻酸异丙酯的含量可以为0.1%-2%。
本发明中,消毒剂组合物可以包含增稠剂。增稠剂可以是聚乙二醇、柠檬酸三乙酯和多糖中的一种或多种。聚乙二醇可以具有各种分子量,例如是聚乙二醇200。在一个实施方案中,增稠剂可以是聚乙二醇200。在另一个实施方案中,增稠剂可以是多糖。增稠剂的含量可以为0.05%-10%。聚乙二醇的含量可以为1-5%。多糖含量可以为0.05%-10%。
多糖是由糖苷键结合的糖链,至少要超过10个的单糖组成的聚合糖高分子碳水化合物,可用通式(C6H10O5)n表示,无甜味,在水中多以胶体形式存在,特别是在pH较低的环境中仍有多糖可以形成凝胶。本发明中,多糖的含量为0.05%-10%,其中多糖包含琼脂糖、葡聚糖、纤维素硫酸酯、壳聚糖、肝素和透明质酸,优选壳聚糖,调节消毒剂的流动性,形成酸性凝胶体系。
本发明中,消毒剂组合物可以包含二苯甲酮-4。本发明中,二苯甲酮-4含量可以为0.1%-1.5%。二苯甲酮-4,又名2-羟基-4-甲氧基二苯甲酮-5-磺酸,紫外线吸收剂UV-284、防晒剂3号、BP-4,分子量为308.31,外观为淡黄色结晶,易溶于水。是一种广谱紫外线吸收剂,具有吸收效率高、无毒、无致畸性副作用,对光、热稳定性好等优点,它同时能够吸收UV-A和UV-B。
本发明提供以下实施方案:
1、一种病毒消毒剂,其按质量百分比计包含:
其余为水,优选去离子水。
2、根据段落1的消毒剂组合物,其中所述乙醇的含量为59%-88%,优选为70%。
3、根据前述任一段的消毒剂组合物,其中所述异丙醇的含量为1.5%-8%,优选为5.5%。
4、根据前述任一段的消毒剂组合物,其中所述尿素的含量为0.2%-8%,优选为2%。
5、根据前述任一段的消毒剂组合物,其中所述有机酸包括柠檬酸、水杨酸、乙酸、乳酸等,优选柠檬酸。
6、根据前述任一段的消毒剂组合物,其中所述有机酸含量为0.2%-6%,优选2%。
7、根据前述任一段的消毒剂组合物,其中所述龙脑包含左旋龙脑、右旋龙脑、异龙脑,优选左旋龙脑。
8、根据前述任一段的消毒剂组合物,其中所述龙脑含量为0.2%-2%,优选为0.2%。
9、根据前述任一段的消毒剂组合物,其中所述锌盐包含葡萄糖酸锌、吡咯烷酮羧酸锌、柠檬酸锌、醋酸锌、乳酸锌、氯化锌和硫酸锌等,优选为吡咯烷酮羧酸锌。
10、根据前述任一段的消毒剂组合物,其中所述锌盐的含量为0.1%-2%,优选为0.2%。
11、根据前述任一段的消毒剂组合物,其中所述增稠剂为聚乙二醇200或柠檬酸三乙酯。
12、根据前述任一段的消毒剂组合物,其中所述增稠剂的含量为1%-5%,优选为2%。
13、根据前述任一段的消毒剂组合物,其中所述芳香剂包含药草型香精,特别是桉叶油醇。
14、根据前述任一段的消毒剂组合物,其中所述芳香剂的含量为0.1%-0.5%,优选为0.1%。
15、根据前述任一段的消毒剂组合物,其中所述油酸的含量为0.1%-1%,优选为0.1%。
16、制备前述任一段的消毒剂的方法,其包括:
(a)将乙醇和异丙醇混合并搅拌均匀;
(b)将然后依次将尿素、有机酸、龙脑加入到(a)溶液中,搅拌至完全溶解;
(c)向(b)溶液中分别加入增稠剂、油酸和芳香剂,边加边搅拌,使溶液混合均匀;
(d)将锌盐加入到水,优选去离子水中,搅拌至完全溶解;
(e)向(d)溶液中缓慢加入(c)溶液,快速搅拌,使溶液混合均匀,得到均相澄明的液体;
上述各步骤都是在常压下进行的,同时搅拌过程中控制温度在20±2℃以下。
17、根据任一段的消毒剂组合物,其特征在于用于物体表面消毒。
18、一种消毒剂组合物,按照质量百分比计包括:
其余为水,优选去离子水。
19、根据段落18的消毒剂组合物,其中所述乙醇的含量为59%-88%,优选为69%。
20、根据段落18或19的消毒剂组合物,其中所述异丙醇的含量为1.5%-8%,优选为5.5%。
21、根据段落18-20中任一项的消毒剂组合物,其中所述尿素的含量为0.2%-8%,优选为2%。
22、根据段落18-21中任一项的消毒剂组合物,其中所述有机酸包括柠檬酸、水杨酸、乙酸、乳酸等,优选柠檬酸和乳酸。
23、根据段落18-22中任一项的消毒剂组合物,其中所述有机酸含量为0.2%-6%,优选5%。
24、根据段落18-23中任一项的消毒剂组合物,其中所述龙脑包含左旋龙脑、右旋龙脑、异龙脑,优选左旋龙脑。
25、根据段落18-24中任一项的消毒剂组合物,其中所述龙脑含量为0.2%-2%,优选为0.2%。
26、根据段落18-25中任一项的消毒剂组合物,其中所述有机锌包含葡萄糖酸锌、吡咯烷酮羧酸锌、柠檬酸锌、醋酸锌、乳酸锌、氯化锌和硫酸锌等,优选吡咯烷酮羧酸锌。
27、根据段落18-26中任一项的消毒剂组合物,其中所述锌盐的含量为0.1%-2%,优选为0.2%。
28、根据段落18-27中任一项的消毒剂组合物,其中所述丙三醇的含量为1%-25%,优选为3%。
29、根据段落18-28中任一项的消毒剂组合物,其中所述维生素E的含量为0.1%-1%,优选为0.5%。
30、根据段落18-29中任一项的消毒剂组合物,其中所述芳香剂包含药草型香精,特别是桉叶油醇。
31、根据段落18-30中任一项的消毒剂组合物,其中所述芳香剂的含量为0.1%-0.5%,优选为0.1%。
32、根据段落18-31中任一项的消毒剂组合物,其中所述二苯甲酮-4的含量为0.1%-1.5%,优选为0.5%。
33、根据段落18-32中任一项的消毒剂组合物,其中所述肉豆蔻酸异丙酯的含量为0.1%-2%,优选为0.5%。
34、根据段落18-33中任一项的消毒剂组合物,其中所述多糖包含琼脂糖、葡聚糖、纤维素硫酸酯、壳聚糖、肝素和透明质酸,优选壳聚糖。
35、根据段落18-34中任一项的消毒剂组合物,其中所述多糖的含量为0.05%-10%,优选为1%。
36、制备段落18-35中任一项所述的消毒剂的方法,其包括:
(a)将乙醇和异丙醇混合并搅拌均匀;
(b)依次将尿素、龙脑、二苯甲酮-4加入到(a)溶液中,搅拌至完全溶解;
(c)向(b)溶液中分别加入丙三醇、肉豆蔻酸异丙酯、维生素E和芳香剂,边加边搅拌,使溶液混合均匀;
(d)将锌盐、多糖、有机酸加入到水,优选去离子水中,加热并搅拌至完全溶解;
(e)向(d)溶液中缓慢加入(c)溶液,快速搅拌,使溶液混合均匀,得到均相澄明的液体;
上述各步骤都是在常压下进行的,同时搅拌过程中控制温度在20-40℃。
37、根据段落18-35中任一项的消毒剂组合物,其中所述消毒剂用于皮肤和黏膜的消毒,特别是用于卫生手和外科手的消毒。
38、根据前述段落中任一项的消毒剂组合物,其可对有生命和无生命物体表面进行有效消毒,特别是对病毒起到杀灭作用,达到严格的消毒要求。
实施例
下面通过实施例和对比例进一步说明本发明,然而本发明并不局限于此。
实施例1-4:产品的制备
如下文表1中所述的原料组成和方法制备实施例1-4和对比例1-5的产品。
表1、实施例1-4及对比例1-5的原料及组成
实施例1或3的制备方法:(a)将乙醇和异丙醇混合并搅拌均匀;(b)然后依次将尿素、柠檬酸、龙脑加入到(a)溶液中,搅拌至完全溶解;(c)向(b)溶液中分别加入聚乙二醇200、油酸和桉叶油醇,边加边搅拌,使溶液混合均匀;(d)将锌盐加入到去离子水中,搅拌至完全溶解;(e)向(d)溶液中缓慢加入(c)溶液,快速搅拌,使溶液混合均匀,得到均相澄明的液体。上述各步骤都是在常压下进行的,同时搅拌过程中控制温度在20±2℃以下。
实施例2或4的制备方法:(a)将乙醇和异丙醇混合并搅拌均匀;(b)依次将尿素、龙脑、二苯甲酮-4加入到(a)溶液中,搅拌至完全溶解;(c)向(b)溶液中分别加入丙三醇、肉豆蔻酸异丙酯、维生素E和桉叶油醇,边加边搅拌,使溶液混合均匀;(d)将有机锌盐、多糖、乳酸加入到去离子水中,加热并搅拌至完全溶解;(e)向(d)溶液中缓慢加入(c)溶液,快速搅拌,使溶液混合均匀,得到均相澄明的液体。上述各步骤都是在常压下进行的,同时搅拌过程中控制温度在20-40℃。
发明人在长期的研究中发现在产品制备过程中应当先混合乙醇和异丙醇,然后添加其它成分,以防止其它情况下发生的组分沉淀的现象。
对比例1-2和4-5的制备方法:(a)将乙醇和异丙醇混合并搅拌均匀;(b)加入其它成分混合均匀,得到均相澄明的液体。实施例3或6的制备方法:将各组分添加到去离子水中,混合均匀,得到均相澄明的液体。
实施例5:实施例1-4的组合物的效果测试
取上述各组合物250ml/瓶×15瓶,根据《消毒技术规范》(2002年版)、中华人民共和国药典(二部)(2015年版)、GB27951-2011《皮肤消毒剂卫生要求》、GB26373-2010《乙醇消毒剂卫生标准》和GB27952-2011《普通物体表面消毒剂的卫生要求》等,对本发明的消毒剂组合物以及各比较组合物的性质进行检验,具体结果如下:
1、悬液定量杀菌试验
试验在20℃恒温控制器内进行,取4.0m L消毒剂加入试管内,20℃恒温控制器预温5min,加入1.0m L菌悬液,静置;1分钟后,取0.5m L所得菌药混悬液加入4.5m L中和剂内,进行中和作用10min后,取样用胰蛋白胨大豆琼脂培养基倾皿检验残留菌数,结果见表2。
2、病毒灭活试验
取滴度为108TCID50的病毒悬液0.1m L和30g/L小牛血清白蛋白0.1m L混合,置于20℃恒温控制器预温5min,再加入0.8m L皮肤消毒剂混合均匀,静置;1分钟后,取0.1m L所得病毒-药混悬液加入0.9m L中和剂内,进行中和作用10min后,取样接种各自宿主细胞,置于培养箱后,观察并记录细胞病变情况,计算半数细胞感染计量(TCID50),结果见表2。
3、一次皮肤刺激试验
(1)选择健康成年、皮肤完好的家兔,在试验前24h,用脱毛剂将兔背部脊柱两侧的毛去掉,不得损伤皮肤。去毛范围,左、右各约3cm×3cm。
(2)次日将样品直接涂于面积为2.5cm×2.5cm的一侧去毛完整皮肤上,然后用一层无刺激塑料膜或油纸覆盖,再用无刺激胶布固定。另一侧去毛皮肤作为空白对照。敷贴时间为4h。试验结束后,用温水除去残留受试物。
(3)分别于去除受试物后1h、24h和48h观察皮肤局部反应,按《消毒技术规范》2002年版分别进行皮肤刺激反应评分和刺激强度分级。结果见表2。
4、多次皮肤刺激试验
(1)选择健康成年、皮肤完好的家兔,在试验前24h,用脱毛剂将兔背部脊柱两侧的毛去掉,不得损伤皮肤。去毛范围,左、右各约3cm×3cm。
(2)次日将样品涂在一侧皮肤上,另一侧涂去离子水作为对照,在涂抹后4h,用水清洗,除去残留物。每天涂抹一次,连续涂抹14d,必要时剪毛。
(3)观察指示,每天观察并记录皮肤反应情况,按《消毒技术规范》2002年版分别进行皮肤刺激反应评分和刺激强度分级。结果见表2。
5、急性经口毒性检测
动物适应饲养4天,取体重18-22g小鼠40只,随机分为4组,每组10只,雌雄各半,试验前禁食,不限制饮水。试验采用限量法,剂量设计为5000mg/kg体重,灌胃给药,给药容积20ml/kg。给药后立即观察动物的中毒表现和死亡情况,其后每日至少观察一次,连续观察14D。试验期间,记录动物每周体重、动物死亡时间,并对死亡动物和观察期满处死动物进行尸体解剖,肉眼观察组织或脏器有无异常。
表2:实施例及对比例的组合物的测试结果
由以上结果可以明显看出,本申请的消毒剂组合物(1)能够形成无色澄清透明液体;(2)具有有效的杀菌对数值,(3)具有有效的病毒(无包膜病毒)灭活对数值(即,灭活对数值≥4.00),能够在短时间(1分钟)内灭活病毒;(4)在适当的润肤保湿成分时对于皮肤没有刺激反应;和(5)各组分在杀灭病毒上具有协同效应。因此,本申请的消毒剂组合物可以用于有生命和无生命的表面的卫生消毒,特别是卫生手消毒。相反,比较组合物或病毒灭活效果差,或者杀菌效果差。在本申请的组合物中添加润肤、保湿和/或防晒成分未影响组合物的消毒性能,在实施例1-4中的组合物对于皮肤等没有刺激作用,因此,能很好的应用皮肤消毒。
以上结合具体实施方式和范例性实例对本发明进行了详细说明,不过这些说明并不能理解为对本发明的限制。本领域技术人员理解,在不偏离本发明精神和范围的情况下,可以对本发明技术方案及其实施方式进行多种等价替换、修饰或改进,这些均落入本发明的范围内。本发明的保护范围以所附权利要求为准。
Claims (14)
2.权利要求1的消毒剂组合物,其还包含保湿润肤剂,优选0.05%-30%保湿润肤剂。
3.权利要求1或2的消毒剂组合物,其还包含芳香剂,优选0.05%-1%芳香剂。
4.前述权利要求中任一项的消毒剂组合物,其还包含增稠剂,优选0.05%-10%增稠剂。
5.前述权利要求中任一项的消毒剂组合物,其中有机酸选自柠檬酸、水杨酸、乙酸和乳酸;
优选地,其中消毒剂包含0.5%-2%柠檬酸,或者1-5%乳酸。
6.前述权利要求中任一项的消毒剂组合物,其中龙脑选自左旋龙脑、右旋龙脑和异龙脑,优选为左旋龙脑。
7.前述权利要求中任一项的消毒剂组合物,其中锌盐选自葡萄糖酸锌、吡咯烷酮羧酸锌、柠檬酸锌、醋酸锌、乳酸锌、氯化锌和硫酸锌,优选为吡咯烷酮羧酸锌。
8.权利要求2的消毒剂组合物,其中保湿润肤剂选自丙三醇、油酸、维生素E和肉豆蔻酸异丙酯;
优选地,保湿润肤剂是油酸或丙三醇、维生素E和肉豆蔻酸异丙酯;
优选地,油酸含量为0.1-1%;丙三醇含量为1%-25%;维生素E含量为0.1%-1%;或肉豆蔻酸异丙酯的含量为0.1%-2%。
9.权利要求3的消毒剂组合物,其中芳香剂包含药草型香精,优选桉叶油醇,优选0.1%-0.5%桉叶油醇。
10.权利要求4的消毒剂组合物,其中增稠剂选自聚乙二醇、柠檬酸三乙酯和多糖;
优选地,其中聚乙二醇的含量为1-5%;多糖含量为0.05%-10%;
优选地,其中聚乙二醇是聚乙二醇200;
优选地,其中多糖选自琼脂糖、葡聚糖、纤维素硫酸酯、壳聚糖、肝素和透明质酸,
优选地,其中多糖是壳聚糖。
11.前述权利要求中任一项的消毒剂组合物,其还包含二苯甲酮-4,优选0.1%-1.5%,优选0.5%二苯甲酮-4。
12.制备权利要求1-11中任一项的消毒剂组合物的方法,其包括:
(a)将乙醇和异丙醇混合并搅拌均匀;和
(b)将尿素、有机酸、龙脑和锌盐溶液加入到(a)溶液中,搅拌至完全溶解,得到均相澄明的液体。
13.权利要求12的方法,其中(b)步骤还包括将保湿润肤剂、芳香剂、增稠剂和/或二苯甲酮-4加入到(a)溶液中。
14.权利要求1-11中任一项的消毒剂组合物用于皮肤消毒,特别是用于卫生手和外科手的消毒,或者用于杀灭有生命和无生命的表面的细菌、真菌和病毒的用途。
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/CN2020/087169 WO2021217324A1 (zh) | 2020-04-27 | 2020-04-27 | 消毒剂组合物、其制备方法和用途 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN113631155A true CN113631155A (zh) | 2021-11-09 |
CN113631155B CN113631155B (zh) | 2024-08-13 |
Family
ID=78332127
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202080021892.7A Active CN113631155B (zh) | 2020-04-27 | 2020-04-27 | 消毒剂组合物、其制备方法和用途 |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN113631155B (zh) |
WO (1) | WO2021217324A1 (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113648326A (zh) * | 2021-08-01 | 2021-11-16 | 杭州氢源素生物科技有限公司 | 一种含有纳米粒子的可灭活病毒的消毒剂及其制备方法 |
CN114632017A (zh) * | 2022-04-27 | 2022-06-17 | 山东利尔康医疗科技股份有限公司 | 一种灭活冠状病毒的手消毒液及其制备方法 |
CN115152793A (zh) * | 2022-07-25 | 2022-10-11 | 独春堂生物科技研究院(菏泽)有限公司 | 一种用于icu病房净化的净化剂及制备方法 |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN116509895B (zh) * | 2023-07-04 | 2023-09-12 | 山东利尔康医疗科技股份有限公司 | 一种低浓度过氧乙酸的手消毒液及制备方法 |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101130102A (zh) * | 2007-09-05 | 2008-02-27 | 黄华春 | 复合型鞋用除臭抑制菌粉及其制作方法 |
CN104474860A (zh) * | 2014-11-04 | 2015-04-01 | 成都彩虹电器(集团)中南有限公司 | 一种抗菌除甲醛的室内空气净化组合物及制备方法 |
CN107212030A (zh) * | 2017-07-05 | 2017-09-29 | 陈魏魏 | 一种鞋垫除菌药液 |
CN107279199A (zh) * | 2017-06-21 | 2017-10-24 | 合肥华盖生物科技有限公司 | 一种室内消毒剂及其制备方法 |
CN108605999A (zh) * | 2018-06-25 | 2018-10-02 | 杭州光启医疗科技发展有限公司 | 一种医疗用杀菌液及其制备方法 |
CN108991046A (zh) * | 2018-09-25 | 2018-12-14 | 潘志刚 | 医用手部消毒剂 |
CN109380301A (zh) * | 2017-08-14 | 2019-02-26 | 孙静 | 一种春夏季草莓杀菌剂及其制备方法 |
CN109566661A (zh) * | 2018-12-11 | 2019-04-05 | 怀化五零三侗医药科技开发有限公司 | 驱虫抑菌凝胶及其制备方法 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1357235A (zh) * | 2000-12-08 | 2002-07-10 | 马渝强 | 聚氧烯烃基胍类消毒剂 |
CN1276714C (zh) * | 2002-04-24 | 2006-09-27 | 宋廷生 | 一种皮肤外用消毒剂及其制备方法 |
CN101642449B (zh) * | 2009-09-08 | 2012-06-27 | 成都顺发消洗科技有限公司 | 一种皮肤粘膜消毒液及其制备方法 |
CN103749551A (zh) * | 2013-12-23 | 2014-04-30 | 杨继建 | 一种预防感冒的空气消毒剂 |
CN104399103B (zh) * | 2014-11-28 | 2017-05-31 | 华南理工大学 | 一种天然空气清新剂及其制备方法 |
CN105288458A (zh) * | 2015-10-16 | 2016-02-03 | 郎勇 | 一种医用消毒液 |
CN105477663A (zh) * | 2015-12-16 | 2016-04-13 | 青岛克立克信息技术有限公司 | 一种消毒杀菌型空气清新剂 |
CN111526718A (zh) * | 2017-10-11 | 2020-08-11 | 马克斯伯里布鲁佩尔有限责任公司 | 顺序输送含水过酸组合物的方法和系统 |
CN114668000B (zh) * | 2020-06-19 | 2023-03-24 | 福建省宇诚环保科技有限公司 | 驱蚊液用缓释安全的无机抗菌剂制备方法以及驱蚊液 |
-
2020
- 2020-04-27 WO PCT/CN2020/087169 patent/WO2021217324A1/zh active Application Filing
- 2020-04-27 CN CN202080021892.7A patent/CN113631155B/zh active Active
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101130102A (zh) * | 2007-09-05 | 2008-02-27 | 黄华春 | 复合型鞋用除臭抑制菌粉及其制作方法 |
CN104474860A (zh) * | 2014-11-04 | 2015-04-01 | 成都彩虹电器(集团)中南有限公司 | 一种抗菌除甲醛的室内空气净化组合物及制备方法 |
CN107279199A (zh) * | 2017-06-21 | 2017-10-24 | 合肥华盖生物科技有限公司 | 一种室内消毒剂及其制备方法 |
CN107212030A (zh) * | 2017-07-05 | 2017-09-29 | 陈魏魏 | 一种鞋垫除菌药液 |
CN109380301A (zh) * | 2017-08-14 | 2019-02-26 | 孙静 | 一种春夏季草莓杀菌剂及其制备方法 |
CN108605999A (zh) * | 2018-06-25 | 2018-10-02 | 杭州光启医疗科技发展有限公司 | 一种医疗用杀菌液及其制备方法 |
CN108991046A (zh) * | 2018-09-25 | 2018-12-14 | 潘志刚 | 医用手部消毒剂 |
CN109566661A (zh) * | 2018-12-11 | 2019-04-05 | 怀化五零三侗医药科技开发有限公司 | 驱虫抑菌凝胶及其制备方法 |
Non-Patent Citations (1)
Title |
---|
银燕 等: "醇类消毒剂及其制剂的发展", 中国消毒学杂志, vol. 30, no. 11, pages 1062 - 1065 * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113648326A (zh) * | 2021-08-01 | 2021-11-16 | 杭州氢源素生物科技有限公司 | 一种含有纳米粒子的可灭活病毒的消毒剂及其制备方法 |
CN113648326B (zh) * | 2021-08-01 | 2023-11-07 | 武汉启航科技发展有限公司 | 一种含有纳米粒子的可灭活病毒的消毒剂及其制备方法 |
CN114632017A (zh) * | 2022-04-27 | 2022-06-17 | 山东利尔康医疗科技股份有限公司 | 一种灭活冠状病毒的手消毒液及其制备方法 |
CN115152793A (zh) * | 2022-07-25 | 2022-10-11 | 独春堂生物科技研究院(菏泽)有限公司 | 一种用于icu病房净化的净化剂及制备方法 |
Also Published As
Publication number | Publication date |
---|---|
WO2021217324A1 (zh) | 2021-11-04 |
CN113631155B (zh) | 2024-08-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN113631155B (zh) | 消毒剂组合物、其制备方法和用途 | |
CA2562329C (en) | Therapeutic antimicrobial compositions and methods | |
CN101048064B (zh) | 抗菌组合物和使用方法 | |
CA2850908C (en) | Aqueous antimicrobial composition containing coniferous resin acids | |
JPH07330505A (ja) | 抗菌性組成物 | |
CN103356738B (zh) | 一种皮肤消毒凝胶及其应用 | |
CN109316536A (zh) | 一种皮肤黏膜消毒剂及其制备方法 | |
WO2006087569A2 (en) | Antimicrobial composition comprising an extract of tarchonanthus camphoratus | |
EP1689416A1 (en) | Disinfecting composition and methods of making and using same | |
TW201216859A (en) | Disinfectant and antiseptic formulation having reduced iodine content | |
WO2008104076A1 (en) | Electrocolloidal silver and echinacea root antimicrobial formulation | |
CN112999331A (zh) | 一种生物杀菌制剂的制备方法和应用 | |
RU2353349C2 (ru) | Средство для лечения болезней суставов | |
US4885310A (en) | Anti-fungal methods and agent | |
CN113939266A (zh) | 用于影响受试者皮肤上微生物群的包含壳聚糖的液体组合物 | |
DE69801820T2 (de) | Verwendung von Dichlorobenzyl Alkohol zur Herstellung einer Zusammenstellung zur topischen Behandlung von Entzündungen | |
CN113521042A (zh) | 一种儿童专用无醇免洗病毒灭活消毒剂及其制备方法 | |
CN109512683B (zh) | 一种聚维酮碘组合物及其制备方法与应用 | |
PL161845B1 (pl) | Sposób wytwarzania preparatów farmaceutycznych i farmakokosmetycznych PL | |
RU2811227C1 (ru) | Антибактериальное средство для обработки рук | |
RU2736859C1 (ru) | Гель дезинфицирующий | |
US20230381217A1 (en) | Liquid composition for use in the prevention or reduction of skin irritation, allergy and/or an infectious disease | |
WO2024028179A1 (en) | Biocidal composition | |
Chen et al. | Research Article Formulation and Evaluation of Antibacterial Creams and Gels Containing Metal Ions for Topical Application | |
CN117224573A (zh) | 兽医牛蹄用清洁消毒剂及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |